Allergan Eyes Salix Tie-Up To Thwart $53B Valeant Takeover
Allergan Inc. has reportedly approached Salix Pharmaceuticals Ltd. and at least one other drugmaker to discuss tie-up prospects, its latest maneuver to worm its way out of a hostile $53 billion...To view the full article, register now.
Already a subscriber? Click here to view full article